Sionna Therapeutics, Inc. Common Stock SION Cash Flow Statement
| FY'25 | ||
|---|---|---|
| -$75.27M-22.0% | ||
| $511K-30.3% | ||
| $12.07M+225% | ||
| -$417K— | ||
| —— | ||
| $2.26M-18.2% | ||
| $1.96M0.0% | ||
| -$2.13M-12.2% | ||
| -$66.3M-25.6% | ||
| $377K+1,296% | ||
| $325.03M+77.8% | ||
| $206.65M+269% | ||
| —— | ||
| $3.64M+2,481% | ||
| $206.02M— | ||
| —— | ||
| $3.05M+1.7% | ||
| $511K-30.3% | ||
| -$2.13M-12.2% | ||
| $2.26M-18.2% | ||
| $1.96M0.0% | ||
| $206.65M+269% | ||
| —— | ||
| —— | ||
| —— | ||
| -$2.13M-12.2% | ||
| —— | ||
| —— | ||
| —— | ||
| -$66.67M-26.2% | ||
| -$66.67M-26.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Sionna Therapeutics, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Sionna Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.